Medically reviewed by Lindsay Cook, PharmD Key Takeaways Ubrelvy is used for treating migraines during an attack but not for ...

A migraine drug can help stop the devastating headaches in their tracks, allowing sufferers to go about their daily lives with little to no symptoms, a new clinical trial has found. People who took ...

The Food and Drug Administration (FDA) has recently intervened regarding a migraine medication advertisement featuring tennis superstar Serena Williams. The FDA’s concerns center around claims that ...

On August 29, 2024, the U.S. Food and Drug Administration (FDA) Office of Prescription Drug Promotion (OPDP) issued an untitled letter to AbbVie, Inc. (AbbVie) regarding a promotional, ...

AbbVie’s ABBV neuroscience franchise delivered solid results in the first quarter of 2026, supported by robust demand across ...

Medicare may cover Ubrelvy (ubrogepant) if you have a plan with prescription drug coverage, such as a Part D plan or a Medicare Advantage (Part C) plan. Ubrelvy is a brand-name drug that doctors may ...

AbbVie makes you the star of its new acute migraine drug ad with tennis phenom Serena Williams. Make that “U”—as in Ubrelvy. The latest TV ad in Ubrelvy’s “Anytime, Anywhere” series shows three ...

No, constipation wasn’t a common side effect reported by people taking Ubrelvy in the drug’s clinical trials. While some other migraine treatments are well known for causing digestive backup, Ubrelvy ...

There’s fewer headaches around for companies that make and market migraine drugs, which are tracking substantial revenue growth. During Pfizer’s Q4 earnings call on Tuesday, chairman/ CEO Albert ...

The U.S. Food and Drug Administration is taking North Chicago-based drugmaker AbbVie to task, warning in a recent letter that a migraine medication commercial featuring Serena Williams is “misleading.

Add Yahoo as a preferred source to see more of our stories on Google. In a new trial, migraine drug ubrogepant (Ubrelvy) helped stop headaches in their tracks, allowing sufferers to go about their ...